{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T06:29:46Z","timestamp":1762928986411,"version":"3.41.2"},"reference-count":26,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2021YFC2700700"],"award-info":[{"award-number":["2021YFC2700700"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82171661"],"award-info":[{"award-number":["82171661"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>This study aimed to determine the correlation between fetal fraction (FF) of cell-free DNA (cf-DNA) and pregnancy complications related to placental dysfunction in Twin Pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This retrospective cohort study analyzed twin pregnant women who underwent non-invasive prenatal testing (NIPT) at 12<jats:sup>+0<\/jats:sup>\u201326<jats:sup>+6<\/jats:sup> weeks of gestation from April 2017 to April 2021. Low fetal fraction (LFF) was defined individually as less than the 25th, 10th, 5th, and 2.5th percentile among all fetal fractions in the cohort. Primary outcomes included gestational hypertension (GH), preeclampsia (PE), gestational diabetes mellitus (GDM), and small for gestational age (SGA). Logistic regression analysis was used to assess the relationship between LFF and pregnancy complications.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 500 twin pregnancies (male-male twins, 245; female-female twins, 255) were included in this study. In LFF group (FF &amp;lt; 25th percentiles), maternal BMI was significantly higher than FF &amp;gt; 75th percentiles (23.6 kg\/m<jats:sup>2<\/jats:sup> vs. 21.3 kg\/m<jats:sup>2<\/jats:sup>; <jats:italic>P<\/jats:italic> &amp;lt; 0.001). The risk of SGA increased gradually from FF &amp;lt; 25th percentiles [adjusted odds ratio (OR), 1.71; 95% confidence interval (CI), 1.07\u20132.99; <jats:italic>P<\/jats:italic> = 0.016] to FF &amp;lt; 2.5th percentiles (adjusted OR, 4.44; 95% CI,1.33\u201314.82; <jats:italic>P<\/jats:italic> &amp;lt; 0.015). In addition, the risks of SGA in both fetuses were higher than the risks of at least one fetus SGA in LFF group. LFF had no correlation with GH, PE, and GDM in twin pregnancy.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>LFF has a strong association with increased risk of SGA in twin pregnancy. Moreover, FF of cf-DNA may provide a new idea for the early screening of diseases related to placental dysfunction in twin pregnancy.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2022.1011366","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T05:10:19Z","timestamp":1669871419000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Correlation of low fetal fraction of cell-free DNA at the early second-trimester and pregnancy complications related to placental dysfunction in twin pregnancy"],"prefix":"10.3389","volume":"9","author":[{"given":"Jiaxin","family":"Li","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xunke","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Tao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bingbing","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chunfang","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Quanfei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tao","family":"Deng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pengbo","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2022,12,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/s0140-6736(97)02174-0","article-title":"Presence of fetal DNA in maternal plasma and serum.","volume":"350","author":"Lo","year":"1997","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1097\/GIM.0b013e3182368a0e","article-title":"DNA sequencing of maternal plasma to detect down syndrome: an international clinical validation study.","volume":"13","author":"Palomaki","year":"2011","journal-title":"Gene Med."},{"key":"B3","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1002\/pd.4625","article-title":"Factors affecting levels of circulating cell-free fetal DNA in maternal plasma and their implications for noninvasive prenatal testing.","volume":"35","author":"Kinnings","year":"2015","journal-title":"Prenat Diagn."},{"key":"B4","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1002\/uog.20290","article-title":"First-trimester screening for trisomies by cfDNA testing of maternal blood in singleton and twin pregnancies: factors affecting test failure.","volume":"53","author":"Galeva","year":"2019","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1093\/humrep\/dey033","article-title":"Cell-free fetal DNA testing in singleton IVF conceptions.","volume":"33","author":"Lee","year":"2018","journal-title":"Hum Reproduc."},{"key":"B6","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1002\/pd.4668","article-title":"The influence of low molecular weight heparin medication on plasma DNA in pregnant women.","volume":"35","author":"Gr\u00f6mminger","year":"2015","journal-title":"Prenat Diagn."},{"key":"B7","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.ajog.2004.09.029","article-title":"Heparin and aspirin attenuate placental apoptosis in vitro: implications for early pregnancy failure.","volume":"192","author":"Bose","year":"2005","journal-title":"Am J Obstet Gynecol."},{"key":"B8","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1002\/uog.18993","article-title":"Association between fetal fraction on cell-free DNA testing and first-trimester markers for pre-eclampsia.","volume":"52","author":"Rolnik","year":"2018","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B9","doi-asserted-by":"publisher","first-page":"1865","DOI":"10.1080\/14767058.2017.1330881","article-title":"Factors affecting cell-free DNA fetal fraction and the consequences for test accuracy. The journal of maternal-fetal & neonatal medicine.","volume":"31","author":"Scott","year":"2018","journal-title":"Int Soc Perinat Obstet."},{"key":"B10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1002\/pd.5609","article-title":"Cell-free DNA fetal fraction in twin gestations in single-nucleotide polymorphism-based noninvasive prenatal screening.","volume":"40","author":"Hedriana","year":"2020","journal-title":"Prenat Diagn."},{"key":"B11","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1373\/clinchem.2013.207951","article-title":"Circulating fetal cell-free DNA fractions differ in autosomal aneuploidies and monosomy X.","volume":"60","author":"Rava","year":"2014","journal-title":"Clin Chem."},{"key":"B12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1081\/prg-120002911","article-title":"The levels of circulatory cell free fetal DNA in maternal plasma are elevated prior to the onset of preeclampsia.","volume":"21","author":"Zhong","year":"2002","journal-title":"Hypertens Pregnancy."},{"key":"B13","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1196\/annals.1368.047","article-title":"Optimized real-time quantitative PCR measurement of male fetal DNA in maternal plasma.","volume":"1075","author":"Zimmermann","year":"2006","journal-title":"Ann N Y Acad Sci."},{"key":"B14","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1002\/pd.4779","article-title":"Adverse perinatal outcomes are more frequent in pregnancies with a low fetal fraction result on noninvasive prenatal testing.","volume":"36","author":"Krishna","year":"2016","journal-title":"Prenat Diagn."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1016\/s0002-9440(10)64127-2","article-title":"Human trophoblast invasion and spiral artery transformation: the role of PECAM-1 in normal pregnancy, preeclampsia, and fetal growth restriction.","volume":"158","author":"Lyall","year":"2001","journal-title":"Am J Pathol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12967-019-1871-x","article-title":"An enrichment method to increase cell-free fetal DNA fraction and significantly reduce false negatives and test failures for non-invasive prenatal screening: a feasibility study.","volume":"17","author":"Hu","year":"2019","journal-title":"J Trans Med."},{"key":"B17","doi-asserted-by":"publisher","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy.","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care."},{"key":"B18","doi-asserted-by":"publisher","first-page":"227","DOI":"10.3760\/cma.j.cn112141-20200114-00039","article-title":"Diagnosis and treatment of hypertension and pre-eclampsia in pregnancy: a clinical practice guideline in China (2020).","volume":"55","year":"2020","journal-title":"Chin J Obstet Gynecol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1855","DOI":"10.1016\/S0140-6736(11)60364-4","article-title":"A global reference for fetal-weight and birthweight percentiles.","volume":"377","author":"Mikolajczyk","year":"2011","journal-title":"Lancet."},{"key":"B20","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1055\/s-0039-1700860","article-title":"Low fetal fraction and birth weight in women with negative first-trimester cell-free DNA screening.","volume":"37","author":"Clapp","year":"2020","journal-title":"Am J Perinatol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.preghy.2020.07.015","article-title":"Association between low fetal fraction of cell free DNA at the early second-trimester and adverse pregnancy outcomes.","volume":"22","author":"Yuan","year":"2020","journal-title":"Pregnancy Hypertens."},{"key":"B22","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.ejogrb.2012.09.006","article-title":"Cell-free fetal DNA and adverse outcome in low risk pregnancies.","volume":"166","author":"Stein","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1111\/1471-0528.15006","article-title":"Implications of failure to achieve a result from prenatal maternal serum cell-free DNA testing: a historical cohort study.","volume":"125","author":"Chan","year":"2018","journal-title":"BJOG."},{"key":"B24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1002\/uog.12331","article-title":"Fetal fraction in maternal plasma cell-free DNA at 11-13 weeks\u2019 gestation: relation to maternal and fetal characteristics.","volume":"41","author":"Ashoor","year":"2013","journal-title":"Ultrasound Obstet Gynecol."},{"key":"B25","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1097\/01.gim.0000241904.32039.6f","article-title":"Quantity versus quality: optimal methods for cell-free DNA isolation from plasma of pregnant women.","volume":"8","author":"Jorgez","year":"2006","journal-title":"Genet Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"2213","DOI":"10.1038\/oby.2012.138","article-title":"Increased death of adipose cells, a path to release cell-free DNA into systemic circulation of obese women.","volume":"20","author":"Haghiac","year":"2012","journal-title":"Obesity."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1011366\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T05:10:22Z","timestamp":1669871422000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2022.1011366\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,1]]},"references-count":26,"alternative-id":["10.3389\/fmed.2022.1011366"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2022.1011366","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2022,12,1]]},"article-number":"1011366"}}